Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.
Medford AJ, Velimirovic M, Gefen Y, Niemierko A, Gerratana L, Davis AA, Clifton K, Keenan J, Podany E, Hensing WL, Reduzzi C, Dai CS, Kiedrowski LA, Spring LM, Ellisen LW, Doebele RC, Cristofanilli M, Getz G, Bardia A.
Medford AJ, et al. Among authors: spring lm.
Breast Cancer Res Treat. 2025 Aug;212(3):437-447. doi: 10.1007/s10549-025-07710-w. Epub 2025 May 29.
Breast Cancer Res Treat. 2025.
PMID: 40439821
Free PMC article.